BlackRock, Inc. 13D and 13G filings for Evolent Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-26 11:50 am Purchase |
2023-12-31 | 13G | Evolent Health, Inc. EVH |
BlackRock Inc. BLK |
8,423,999 7.300% |
722,080![]() (+9.38%) |
Filing |
2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Evolent Health, Inc. EVH |
BlackRock Inc. BLK |
7,701,919 7.600% |
1,811,956![]() (+30.76%) |
Filing |
2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Evolent Health, Inc. EVH |
BlackRock Inc. BLK |
5,889,963 6.600% |
287,730![]() (+5.14%) |
Filing |
2021-01-29 09:57 am Sale |
2020-12-31 | 13G | Evolent Health, Inc. EVH |
BlackRock Inc. BLK |
5,602,233 6.500% |
-766,106![]() (-12.03%) |
Filing |